Favorable long-term toxicity for salvage low-dose rate prostate brachytherapy for recurrent prostate cancer after external beam radiotherapy from a phase II prospective trial (NRG Oncology/RTOG 0526).

Brenneman, Randall J; Soffen, Edward; Gay, Hiram A; Orio, Peter F; Christodouleas, John P; Baumann, John C; Baumann, Brian C

Brenneman, Randall J; Soffen, Edward; Gay, Hiram A; Orio, Peter F; Christodouleas, John P; Baumann, John C; Baumann, Brian C.

Afiliação

Brenneman RJ; Department of Radiation Oncology, Washington University in St. Louis, St. Louis, MO, USA.
Soffen E; Princeton Radiation Oncology, Princeton, NJ, USA.
Gay HA; Department of Radiation Oncology, Washington University in St. Louis, St. Louis, MO, USA.
Orio PF; Department of Radiation Oncology, Dana-Farber Cancer Institute, and Brigham and Women's Hospital, Boston, MA, USA.
Christodouleas JP; Harvard Medical School, Boston, MA, USA.
Baumann JC; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
Baumann BC; Princeton Radiation Oncology, Princeton, NJ, USA.

Transl Androl Urol ; 8(Suppl 3): S265-S270, 2019 Jul.

Article em En | MEDLINE | ID: mdl-31392141

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article